Showing results (431-440 of 1,252) with videos related to

Sort By:
Pageof 126
Parkinsonism & Related Disorders|November 10, 2021
Neurogenic orthostatic hypotension in early stage Parkinson's disease: New insights from the first 105 patients of the BoProPark studyFrancesca Baschieri, Luisa Sambati, Pietro Guaraldi, et al.
Human Mutation|October 2, 2004
A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C diseaseEnza Di Leo, Francesca Panico, Patrizia Tarugi, et al.
Plos One|May 5, 2011
Monitoring procalcitonin in febrile neutropenia: what is its utility for initial diagnosis of infection and reassessment in persistent fever?James Owen Robinson, Frédéric Lamoth, Frank Bally, et al.
Virology|April 30, 1985
Structure of eight streptococcal bacteriophagesD J Moynet, A E Colon-Whitt, G B Calandra, et al.
Gene|February 28, 2002
Functional analysis of the promoter of human sterol 27-hydroxylase gene in HepG2 cellsRita Garuti, Maria Antonietta Croce, Luana Piccinini, et al.
Rapid Communications in Mass Spectrometry : RCM|September 29, 2015
Effects of demineralization on the stable isotope analysis of bone samplesCalandra N Turner Tomaszewicz, Jeffrey A Seminoff, Matthew D Ramirez, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 9, 2013
Self-assembly in poly(dimethylsiloxane)-poly(ethylene oxide) block copolymer template directed synthesis of Linde type A zeoliteLucio Bonaccorsi, Pietro Calandra, Mikhail A Kiselev, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|July 16, 2013
Enhancement of electrorheological effect by particle-fluid interactionF Aliotta, P Calandra, M Pochylski, et al.
Molecular Aspects of Medicine|March 15, 2025
Duration of systemic antifungal therapy for patients with invasive fungal diseases: A reassessmentSimon B Gressens, Claire Rouzaud, Frederic Lamoth, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 17, 2004
Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumoniaV Erard, O Lamy, P-Y Bochud, et al.
Pageof 126